is tirzepatide a glp-1 medication may be most effective for weight loss Tirzepatide (GLP-1 / GIP)

Mechanisms Beyond Adiposity: The substantial MACE reduction not explained by weight or waist changes points to direct cardiovascular effects, including: Improved endothelial function and vascular health Anti-inflammatory pathways via central GLP-1 receptor signalling Favourable effects on blood pressure and lipid metabolism Possible early adipose tissue metabolic improvements before measurable mass reduction 3

Dehydration is one of the most common culpritspatients taking semaglutide often feel less thirsty due to appetite suppression, leading to insufficient fluid intake and muscle dysfunction

Losers are defending the junk-food past

Patient C: Jessica, 34, with a BMI of 31 and PCOS

Here's what we'll cover Here's what we'll cover Here's what we'll cover Key takeaways Research on the safety of semaglutide while breastfeeding is extremely limited